Abstract
Protein aggregates/inclusions are pathological hallmarks of a wide spectrum of neurodegenerative diseases. These aggregates have different shapes, sizes, distribution, and protein composition, which are unique features used for pathological diagnosis. The aggregates per se are also used as molecular targets for designing therapeutic approaches. Detection of these aggregates is generally achieved by using immunostaining methods, most often by immunohistochemistry. In clinical and pathologic practice, the neurologic tissues to be examined are generally fixed with formalin and processed to paraffin-embedded tissue blocks. These treatments result in covalent cross-linking of the protein molecules and preserve the tissue morphology, but dramatically mask the antigens, making it often difficult to detect the aggregates. Therefore, removal of the cross-linking of antigens is a critical step for effective detection of these aggregates. In this chapter, we discuss and present immunostaining methods with a focus on the effectiveness of antigen-retrieval methods. In our experience, a treatment of tissues at 125°C for 20 min represents a relatively ideal antigen-retrieval method not only preserving the tissue morphology, but also providing efficient antigen retrieval. Using this method, we successfully detected some protein aggregates that escaped detection when other antigen-retrieval methods were employed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taylor JP, Hardy J, Fischbeck KH. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991–5.
Aguzzi A, O’Connor T. (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov. 9,237–48.
Lansbury PT, Lashuel HA. (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774–9.
Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE, et al. (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114 ( Pt 2), 775–88.
Lowe J. (1994) New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci. 124 Suppl., 38–51.
Shibata N, Hirano A, Kobayashi M, Siddique T, Deng HX, Hung WY, et al. (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol. 55, 481–90.
Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 61, 427–34.
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–3.
Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, et al. (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 67, 739–48.
Dohm CP, Kermer P, Bahr M. (2008) Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication. Neurodegener Dis. 5, 321–38.
Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci USA. 103, 7142–7.
Krainc D. (2010) Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases. Arch Neurol. 67, 388–92.
Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. (2008) Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases. Mol Med. 14, 451–64.
Dapson RW. (2007) Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech Histochem. 82, 133–40.
Shi SR, Key ME, Kalra KL. (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39, 741–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Deng, HX., Bigio, E.H., Siddique, T. (2011). Detection of Protein Aggregation in Neurodegenerative Diseases. In: Manfredi, G., Kawamata, H. (eds) Neurodegeneration. Methods in Molecular Biology, vol 793. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-328-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-61779-328-8_17
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-327-1
Online ISBN: 978-1-61779-328-8
eBook Packages: Springer Protocols